Proteomics

Dataset Information

0

Integration of metabolomics and transcriptomics to reveal metabolic characteristics and key targets associated with cisplatin resistance in non-small cell lung cancer


ABSTRACT: Continuous exposure to cisplatin can induce drug resistance to limit efficacy, however, the underlying mechanisms correlated to cisplatin resistance are still unclear. Drug-sensitive A549 cells and cisplatin-resistant A549/DDP cells were used to explore the potential metabolic pathways and key targets associated with cisplatin resistance by integrating untargeted metabolomics with transcriptomics. The results of comprehensive analyses showed that 19 metabolites were significantly changed in A549/DDP vs A549 cells, and some pathways had a close relationship with cisplatin resistance, such as the biosynthesis of aminoacyl-tRNA, glycerophospholipid metabolism, and glutathione metabolism. Moreover, transcriptomics analysis showed glutathione metabolism was also obviously affected in A549/DDP, which indicated that glutathione metabolism played an import role in the process of drug resistance. Meanwhile, transcriptomics analysis suggested the four enzymes related to glutathione metabolism - CD13, GPX4, RRM2B, and OPLAH - as potential targets of cisplatin resistance in NSCLC. Further studies identified the over-expressions of these four enzymes in A549/DDP. The elucidation of mechanism and discovery of new potential targets may help us have a better understanding of cisplatin resistance.

INSTRUMENT(S): Agilent MassHunter format

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung, Cell Culture

DISEASE(S): Lung Carcinoma In Situ

SUBMITTER: shi yuhuan  

LAB HEAD: Yongfang Yuan1

PROVIDER: PXD013265 | Pride | 2019-08-12

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
NEGraw.xml Xml
POS-raw.xml Xml
result.xml Xml
Items per page:
1 - 3 of 3
altmetric image

Publications

Integration of Metabolomics and Transcriptomics To Reveal Metabolic Characteristics and Key Targets Associated with Cisplatin Resistance in Nonsmall Cell Lung Cancer.

Shi Yuhuan Y   Wang Yuanyuan Y   Huang Wanying W   Wang Yang Y   Wang Rong R   Yuan Yongfang Y  

Journal of proteome research 20190816 9


Continuous exposure to cisplatin can induce drug resistance to limit efficacy; however, the underlying mechanisms correlated with cisplatin resistance are still unclear. Drug-sensitive A549 cells and cisplatin-resistant A549/DDP cells were used to explore the potential metabolic pathways and key targets associated with cisplatin resistance by integrating untargeted metabolomics with transcriptomics. Data are available via ProteomeXchange with identifier PXD013265. The results of comprehensive an  ...[more]

Similar Datasets

2013-01-15 | E-GEOD-43493 | biostudies-arrayexpress
2013-01-15 | E-GEOD-43249 | biostudies-arrayexpress
2012-02-24 | E-MEXP-3123 | biostudies-arrayexpress
2024-10-20 | PXD053902 | Pride
2022-02-17 | PXD025778 | Pride
2023-03-10 | PXD021779 | Pride
2021-09-09 | PXD017645 | Pride
2017-05-02 | PXD002394 | Pride
2015-08-05 | E-GEOD-66549 | biostudies-arrayexpress
2019-11-11 | E-MTAB-7437 | biostudies-arrayexpress